Delivery Order SPE2DB24D2010-SPE2DB25FABJL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,658.18 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. The contract falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $14,237.99. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract represents a single delivery order placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $4,620.99 and a firm fixed price structure. The order was issued on September 10, 2025, with an ultimate completion date of September 11, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on August 8, 2025, with a ceiling value of $6,644.43 and firm fixed pricing. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $76,733.23 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $4,345.92 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a non-set-aside award issued through competitive procurement. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) valued at $4,159.32. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract represents a single delivery transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,063.89 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180 count) under a firm fixed price contract. This non-set-aside award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,810.80 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed price contract. The order was placed on September 9, 2025, with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order as part of its extensive federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $9,376.56 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (60-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABJLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,069.24 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count packages). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor contract running through December 2026 that provides comprehensive global pharmaceutical support. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines to support military healthcare programs worldwide. This specific order for Janumet, a diabetes medication combining metformin and sitagliptin, exemplifies the routine pharmaceutical procurement conducted through this overarching vehicle to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.1k | 9/24/25 |